1 – 5 of 5
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Clinical outcome of percutaneous RF-ablation of non-operable patients with liver metastasis from breast cancer
(
- Contribution to journal › Article
- 2014
-
Mark
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group
(
- Contribution to journal › Article
-
Mark
PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients
(
- Contribution to journal › Article
- 2013
-
Mark
Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine
(
- Contribution to journal › Article
- 2011
-
Mark
Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group
(
- Contribution to journal › Article